MucosaTec GmbH – the mucus engineering company

We have made it our mission to improve the properties of our protective mucus layer with our innovative concept and protect people from respiratory infections.

Our first product will be a broadly effective nasal spray against various influenza viruses, which is currently in the preclinical phase. 

History of MucosaTec GmbH

The COVID-19 pandemic has opened humanity’s eyes. There is an urgent need for broadly effective antiviral therapeutics that are immediately available and readily adaptable. For this reason, the Federal Agency for Disruptive Innovation SPRIND (Bundesagentur für Sprunginnovationen) launched the “broad-spectrum antivirals” challenge in 2021. Competing against 10 other teams, Team MucBoost’s highly innovative idea fought its way through to the final. MucosaTec GmbH was created as a spin-off of this challenge and is now set to bring Team MucBoost’s successful concept to the market – in the form of a broad-spectrum nasal spray against flu viruses.

Company Location

MucosaTec GmbH is spread over two locations with the Head quarter, Formulation and Analytics in Schiffweiler and R&D and Manufacturing in Berlin. This division enables a large cooperation radius and ensures future collaboration between the partners established in MucBoost in industry and academic research.

Our Founders

Dr. Marius Hittinger

Dr. Anja Himmelstein

Prof. Daniel Lauster

Our Team

Dr. Carina Fendahl

Thomas Kuhn

David Birreck

Silke Benndorf

Seray Şahsuvar

Prisca Mohr-Bartholome

Annika Dehne

Malte-Ole Schneemann

Dr. Marius Wirth

Dr. Markus Bardua